NEW YORK (GenomeWeb) – Meridian Bioscience issued preliminary fiscal year 2016 earnings after the close of the market on Tuesday, reporting a 1 percent year-over-year increase in revenues.

Meridian expects revenues of $196 million for its fiscal year ending Sept. 30, 2016, including fourth quarter revenues of $47 million. Diluted earnings per share should be in the $.75 to $.76 range for the year, compared to $.85 per share in for FY2015.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.